Milestone Pharmaceuticals
MIST
MIST
40 hedge funds and large institutions have $30.9M invested in Milestone Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.
Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
9
Reduced
10
Closed
7
Calls
$411K
Puts
$160K
Net Calls
+$251K
Net Calls Change
-$60K
Top Buyers
| 1 |
LPC
1
Lion Point Capital
New York
|
$2.76M |
| 2 |
2
Morgan Stanley
New York
|
$2.3M |
| 3 |
AFA
3
Alta Fundamental Advisers
New York
|
$2.79M |
| 4 |
4
BlackRock
New York
|
$5.46M |
| 5 |
BCM
5
BML Capital Management
Zionsville,
Indiana
|
$739K |
Top Sellers
| 1 |
VA
1
VR Adviser
New York
|
$1.54M |
| 2 |
2
Goldman Sachs
New York
|
$2.26M |
| 3 |
AAA
3
Affinity Asset Advisors
New York
|
$0 |
| 4 |
4
Barclays
London,
United Kingdom
|
$426K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$17.8K |
